Crossmark Global Holdings Inc. increased its position in Chemours Co (NYSE:CC) by 2.2% during the 1st quarter, HoldingsChannel.com reports. The firm owned 23,040 shares of the specialty chemicals company’s stock after purchasing an additional 500 shares during the period. Crossmark Global Holdings Inc.’s holdings in Chemours were worth $856,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Live Your Vision LLC grew its stake in shares of Chemours by 6.3% in the first quarter. Live Your Vision LLC now owns 4,993 shares of the specialty chemicals company’s stock worth $198,000 after acquiring an additional 295 shares during the last quarter. Financial Architects Inc lifted its holdings in shares of Chemours by 39.2% during the fourth quarter. Financial Architects Inc now owns 1,421 shares of the specialty chemicals company’s stock valued at $40,000 after purchasing an additional 400 shares in the last quarter. Gulf International Bank UK Ltd lifted its holdings in shares of Chemours by 1.0% during the first quarter. Gulf International Bank UK Ltd now owns 40,350 shares of the specialty chemicals company’s stock valued at $1,499,000 after purchasing an additional 400 shares in the last quarter. TCI Wealth Advisors Inc. lifted its holdings in shares of Chemours by 27.5% during the first quarter. TCI Wealth Advisors Inc. now owns 1,916 shares of the specialty chemicals company’s stock valued at $71,000 after purchasing an additional 413 shares in the last quarter. Finally, Legacy Bridge LLC lifted its holdings in shares of Chemours by 100.0% during the first quarter. Legacy Bridge LLC now owns 1,200 shares of the specialty chemicals company’s stock valued at $45,000 after purchasing an additional 600 shares in the last quarter. 82.18% of the stock is currently owned by institutional investors.

CC stock opened at $23.74 on Thursday. Chemours Co has a fifty-two week low of $23.36 and a fifty-two week high of $53.25. The company has a debt-to-equity ratio of 5.18, a quick ratio of 1.04 and a current ratio of 1.81. The stock has a market capitalization of $4.15 billion, a price-to-earnings ratio of 4.19, a PEG ratio of 0.39 and a beta of 2.20.

Chemours (NYSE:CC) last posted its earnings results on Thursday, May 2nd. The specialty chemicals company reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.93 by ($0.30). Chemours had a net margin of 12.60% and a return on equity of 87.75%. The firm had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same period in the prior year, the company posted $1.41 EPS. The firm’s revenue was down 20.5% compared to the same quarter last year. On average, equities analysts predict that Chemours Co will post 4.22 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Thursday, May 16th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 4.21%. The ex-dividend date of this dividend is Wednesday, May 15th. Chemours’s dividend payout ratio is 17.64%.

A number of research analysts have recently issued reports on CC shares. ValuEngine downgraded Chemours from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 1st. Zacks Investment Research raised Chemours from a “sell” rating to a “hold” rating in a report on Monday, March 18th. SunTrust Banks increased their target price on Chemours to $40.00 and gave the company a “hold” rating in a report on Tuesday, February 19th. Susquehanna Bancshares reissued a “neutral” rating and issued a $37.00 target price on shares of Chemours in a report on Tuesday, February 19th. Finally, Citigroup reissued a “buy” rating and issued a $43.00 target price on shares of Chemours in a report on Wednesday, February 20th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $46.00.

In other Chemours news, VP Amy Trojanowski sold 10,129 shares of the company’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $39.10, for a total value of $396,043.90. Following the completion of the sale, the vice president now owns 54,795 shares in the company, valued at $2,142,484.50. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Mark Newman sold 59,210 shares of the company’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $38.26, for a total value of $2,265,374.60. Following the completion of the sale, the vice president now owns 94,261 shares of the company’s stock, valued at approximately $3,606,425.86. The disclosure for this sale can be found here. In the last three months, insiders sold 101,924 shares of company stock worth $3,924,730. 2.34% of the stock is owned by corporate insiders.

WARNING: “Crossmark Global Holdings Inc. Purchases 500 Shares of Chemours Co (CC)” was published by Marea Informative and is owned by of Marea Informative. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.mareainformativa.com/news/2019/05/16/crossmark-global-holdings-inc-purchases-500-shares-of-chemours-co-cc.html.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.

See Also: Do Tariffs Work?

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Co (NYSE:CC).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.